The concept of control of COPD in clinical practice.

The concept of control of COPD in clinical practice.

Int J Chron Obstruct Pulmon Dis. 2014;9:1397-405

Authors: Soler-Cataluña JJ, Alcázar-Navarrete B, Miravitlles M

Abstract
Treatment of chronic obstructive pulmonary disease (COPD) requires a personalized approach according to the clinical characteristics of the patients, the level of severity, and the response to the different therapies. Furthermore, patients with the same level of severity measured by the degree of airflow obstruction or even with multidimensional indices may have very different symptoms and limitations for daily activities. The concept of control has been extensively developed in asthma but has not been defined in COPD. Here, we propose a definition of COPD control based on the concepts of impact and stability. Impact is a cross-sectional concept that can be measured by questionnaires such as the COPD Assessment Test or the Clinical COPD Questionnaire. Alternatively, impact can be assessed by the degree of dyspnea, the use of rescue medication, the level of physical activity, and sputum color. Stability is a longitudinal concept that requires the absence of exacerbations and deterioration in the aforementioned variables or in the COPD Assessment Test or Clinical COPD Questionnaire scores. Control is defined by low impact (adjusted for severity) and stability. The concept of control in COPD can be useful in the decision making regarding an increase or decrease in medication in the stable state.

PMID: 25548521 [PubMed – in process]

View full post on pubmed: asthma

SLIT-tablet seems safe for patients with asthma, allergic rhinitis – Clinical Advisor

SLIT-tablet seems safe for patients with asthma, allergic rhinitis
Clinical Advisor
HealthDay News — For patients with asthma and allergic rhinitis with/without conjunctivitis (AR/C), treatment with a Timothy grass sublingual immunotherapy tablet (SLIT-tablet) may be safe, results of research published in Allergy indicate. Using data
Sublingual immunotherapy tablet safe in asthma patientsMedical Xpress

all 5 news articles »

View full post on asthma – Google News

COPD, Asthma Treatment Aided By Computerized Clinical Decision Support … – Lung Disease News


Lung Disease News

COPD, Asthma Treatment Aided By Computerized Clinical Decision Support
Lung Disease News
However, despite CCDSS use in a variety of diseases, its systematic impact on the clinical assessment of chronic respiratory diseases, such as asthma and COPD, is still lacking. In this new research, the authors performed a systematic review to present

View full post on asthma – Google News

Validation Of A Questionnaire Against Clinical Assessment In The Diagnosis Of Asthma In Schoolchildren.

Related Articles

Validation Of A Questionnaire Against Clinical Assessment In The Diagnosis Of Asthma In Schoolchildren.

J Asthma. 2014 Sep 18;:1-25

Authors: Hansen TE, Evjenth B, Holt J

Abstract
Abstract Aim: A questionnaire has been used repeatedly in cross sectional studies to determine the prevalence of asthma, allergic rhinoconjunctivitis (AR) and eczema among schoolchildren in Nordland County, Norway. The current study was designed to validate the questionnaire against clinical assessment as the diagnostic gold standard and to investigate the extent of possible misclassification. Methods: A subsample of 801 schoolchildren of 4150, whose parents had answered a questionnaire covering asthma and atopic diseases, underwent a detailed clinical evaluation including a standardized interview, a clinical examination, skin prick tests (SPT), blood samples, spirometry an exercise treadmill test (EIB test) and measurement of exhaled nitrogen oxide (FeNO). Results: The questionnaire had a sensitivity of 0.96 and a specificity of 0.87 for the diagnosis of asthma ever compared to clinical assessment. The overall agreement (kappa) was 0.80. After clinical assessment the prevalence of asthma ever was adjusted from 17.6 % to 16.9 % (95% CI: 15.8-18.0). The most sensitive and specific questions in identifying asthmatic children by the questionnaire were questions asking about diagnosis (‘Has the child ever had asthma?’) rather than those covering asthma symptoms such as wheeze, shortness of breath and/or cough. A positive exercise test increased the posttest probability for the asthma diagnosis only to a minimal degree. Conclusion: Based on the good agreement between the questionnaire responses and the clinical assessments, it is concluded that the questionnaire had good validity and served as a useful epidemiological tool. Detailed clinical testing added little additional information.

PMID: 25233047 [PubMed – as supplied by publisher]

View full post on pubmed: asthma

Teva’s Reslizumab Shows Reduction In Asthma Exacerbations In Clinical Studies – RTT News

Teva's Reslizumab Shows Reduction In Asthma Exacerbations In Clinical Studies
RTT News
Teva Pharmaceutical Industries Ltd. (TEVA: Quote) announced that reslizumab, an investigational anti-IL-5 monoclonal antibody, demonstrated clear levels of efficacy in achieving the primary endpoint of reduction in the frequency of clinical asthma …

and more »

View full post on asthma – Google News

Asthma mortality rate highest in older women – Clinical Advisor


World First Travel Insurance

Asthma mortality rate highest in older women
Clinical Advisor
An increased risk of osteoporosis, glaucoma, cataracts, and adrenal suppression in older women using inhalers; an increased rate of depression and more severe depression with severe asthma; and a diminished awareness of breathlessness are common …
Asthma Outcomes Worse in Older WomenHCPLive
Take control, asthma sufferers urgedWorld First Travel Insurance
Asthmatics 'don't know they are in danger'Independent Online
Allergic Living
all 10 news articles »

View full post on asthma – Google News

Secondhand smoke ups asthma, rhinitis, eczema risks through adolescence – Clinical Advisor

Secondhand smoke ups asthma, rhinitis, eczema risks through adolescence
Clinical Advisor
Exposure to secondhand smoke during infancy was associated with an overall elevated risk of asthma (OR=1.23; 95% CI:1.01–1.51), rhinitis (OR=1.18; 95% CI:1.01–1.39), and eczema (OR=1.26; 95% CI:1.09–1.45) for up to 16 years, reported the inspectors.

and more »

View full post on asthma – Google News